v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   87,452,835      
Beginning balance at Dec. 31, 2024 $ 59,077 $ 9 $ 1,506,315 $ (80) $ (1,447,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 21,509   21,509    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   1,529,161      
Issuance of common stock under the equity incentive plan and proceeds from exercise 4,706   4,706    
Employee stock purchase program purchase and expense (in shares)   120,351      
Employee stock purchase program purchase and expense 2,168   2,168    
Induced conversion on 2029 Notes 0        
Foreign currency translation adjustments (418)     (418)  
Unrealized loss on marketable debt securities (314)     (314)  
Net loss (53,981)       (53,981)
Ending balance (in shares) at Jun. 30, 2025   89,102,347      
Ending balance at Jun. 30, 2025 32,747 $ 9 1,534,698 (812) (1,501,148)
Beginning balance (in shares) at Mar. 31, 2025   88,787,429      
Beginning balance at Mar. 31, 2025 32,823 $ 9 1,522,050 (843) (1,488,393)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 10,331   10,331    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   194,567      
Issuance of common stock under the equity incentive plan and proceeds from exercise $ 463   463    
Employee stock purchase program purchase and expense (in shares) 120,351        
Employee stock purchase program purchase and expense $ 1,854   1,854    
Induced conversion on 2029 Notes 0        
Foreign currency translation adjustments 268     268  
Unrealized loss on marketable debt securities (237)     (237)  
Net loss (12,755)       (12,755)
Ending balance (in shares) at Jun. 30, 2025   89,102,347      
Ending balance at Jun. 30, 2025 32,747 $ 9 1,534,698 (812) (1,501,148)
Beginning balance (in shares) at Dec. 31, 2025   90,922,868      
Beginning balance at Dec. 31, 2025 114,828 $ 9 1,588,721 (1,189) (1,472,713)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation $ 37,008   37,008    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares) 1,353,230 3,173,117      
Issuance of common stock under the equity incentive plan and proceeds from exercise $ 32,570   32,570    
Employee stock purchase program purchase and expense (in shares)   78,782      
Employee stock purchase program purchase and expense 3,283   3,283    
Induced conversion on 2029 Notes 91,340   91,340    
Foreign currency translation adjustments 917     917  
Unrealized loss on marketable debt securities (845)     (845)  
Net loss (71,899)       (71,899)
Ending balance (in shares) at Jun. 30, 2026   94,174,767      
Ending balance at Jun. 30, 2026 24,522 $ 9 1,570,242 (1,117) (1,544,612)
Beginning balance (in shares) at Mar. 31, 2026   92,403,744      
Beginning balance at Mar. 31, 2026 98,728 $ 9 1,609,596 (1,062) (1,509,815)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 21,318   21,318    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   1,692,241      
Issuance of common stock under the equity incentive plan and proceeds from exercise $ 27,841   27,841    
Employee stock purchase program purchase and expense (in shares) 78,782        
Employee stock purchase program purchase and expense $ 2,827   2,827    
Induced conversion on 2029 Notes 91,340   91,340    
Foreign currency translation adjustments 470     470  
Unrealized loss on marketable debt securities (525)     (525)  
Net loss (34,797)       (34,797)
Ending balance (in shares) at Jun. 30, 2026   94,174,767      
Ending balance at Jun. 30, 2026 $ 24,522 $ 9 $ 1,570,242 $ (1,117) $ (1,544,612)